Presenters

Teresa Knoop is an Assistant Director of the Clinical Trials Shared
Resource at the Vanderbilt-Ingram Cancer Center in Nashville, TN. She
graduated from Murray State University in Murray,KY with a BSN and
earned her Master’s Degree in Nursing from the Vanderbilt University
School of Nursing. Teresa is an Advanced Oncology Certified Nurse
through the Oncology Nursing Society and is a Certified Clinical Research
Professional through the Society of Clinical Research Associates. She has
published articles in nursing journals and speaks frequently on the topics
of molecularly targeted cancer therapies and cancer clinical trials

Visit her Linked-In for more: Linked-In

Kimberly Halla, MSN, FNP-C, is a patient-oriented Family Nurse Practitioner at Arizona Oncology Associates PC in Scottsdale, Arizona. She received her MSN degree with honors from Grand Canyon University in Phoenix, Arizona in 2015. Ms. Halla is an expert in the field of oncology and medical surgical care. At Arizona Oncology Associates PC, she is responsible for the continued assessment and interventions of all active chemotherapy patients from initiation of treatment through survivorship, the development of individualized survivorship programs in compliance with the Oncology Care Model, and their continued surveillance and assessment as per the National Comprehensive Cancer Network for a
large Gynecologic Oncology practice.

Ms. Halla has been caring for oncology patients in multiple roles since 2008. She has a background in education and truly believes that this is at the heart of what she does. She continues to participate in
the ongoing education of her peers and colleagues to include caring for the gyn/onc patient after surgery and during chemotherapy and their survivorship. As a subinvestigator on multiple research trials, she has been able to see firsthand new and exciting treatment options that continue to improve the lives of patients.

Clara Beaver, DNP, RN, AOCNS, ACNS, BC has been an
oncology nurse for over 25 years. Ms. Beaver has been a clinical
nurse specialist at Karmanos for over 19 years. She earned her
DNP from Grand Valley State University in 2023. She is also very
active with ONS and ONCC, just coming off the ONCC board after
6 years of service.

Chaitali Nangia, M.D., attended Lady Hardinge Medical College in New Delhi, India followed by a residency at Rush/Resurrection Westlake Hospital in Melrose Park, Illinois. She completed her fellowship in Hematology/Oncology at Josephine Ford Cancer Center at Henry Ford Hospital in Detroit, Michigan. Dr. Nangia then joined University of California Irvine as an associate professor in the Hematology/Oncology Division and associate program director of the Hematology/Oncology Fellowship program. Before joining Hoag, Dr. Nangia last spent her time as medical director at the Chan Soon Shiong Institute for Medicine where she ran several phase 1 clinical trials. Dr. Nangia is board certified in Hematology/Oncology and Internal Medicine.

Dr. Nangia has a particular interest in breast cancer, as well as head and neck cancers.

She has received several awards and honors throughout her career including being named Teacher of the Year for three years consecutively for the UCI Hematology/Oncology Division. Dr. Nangia has held professorships at University of California at Irvine, Michigan State University and Henry Ford Macomb Hospital in Warren, Michigan among others.

She has more than two decades of research experience, serving as the primary investigator on several clinical research trials. Dr. Nangia has co-authored numerous peer-reviewed publications and abstracts and given clinical presentations throughout the U.S. and abroad. Dr. Nangia has joined Hoag to initiate a cellular therapy program, bringing solid tumor NK cell therapy to Orange County patients.

She is a member of the American Society of Clinical Oncology, the American Society of Hematology, the Southwest Oncology Group (SWOG) and the American Association of Physicians of Indian Origin (AAPIO).

Sandra E. Kurtin, PhD, ANP-BC, AOCN, FAPO, graduated from the University of Arizona with a Bachelor of Science in Nursing with high distinction, a Master of Science in Oncology Nursing, post-graduate certification in both Geriatric and Adult Practice, and a PhD in Nursing. Her research focus is on heath technology engagement, communicative health literacy, and health self-management among older adult cancer survivors. She is currently employed as a hematology/oncology nurse practitioner at the University of Arizona Cancer Center and serves as Assistant Professor of Clinical Medicine and Adjunct Clinical Assistant Professor of Nursing at the University of Arizona. Dr. Kurtin has 34 years of oncology nursing experience.

Michael Mauro is Attending Physician, Professor of Medicine, Director, Chronic Myeloid Leukemia Program, and Member, Memorial Sloan Kettering Cancer Center, in New York City. After receiving his BS and MD from Dartmouth College and Dartmouth Medical School in New Hampshire, he completed both residency and fellowship training at the New York-Presbyterian Hospital/Weill Cornell Medical College in Manhattan. Before joining Memorial Sloan Kettering, Dr. Mauro was on the faculty of Oregon Health and Sciences University for 13
years, where he directed the CML clinical trial program and was involved in the early development and sentinel clinical studies of ABL kinase inhibitors for CML. Dr. Mauro’s clinical expertise is in treating patients with chronic myeloid leukemia (CML) as well as other myeloproliferative disorders, including myelofibrosis, polycythemia, and thrombocytosis as well as less common conditions such as eosinophilic and mast cell disorders. His research interests are development of novel agents for CML, increasing the option of treatment free remission (TFR) / functional cure in CML and identification and management of tyrosine kinase inhibitor related adverse events, specifically cardiovascular events. He holds positions on the boards of the International CML Foundation, the MAX Foundation, and the Leukemia and Lymphoma Society.

Dr. J. Randolph Hecht is a Professor of Clinical Medicine at the David Geffen School of Medicine at UCLA School of Medicine. He holds the Carol and Saul Rosenzweig Chair for Cancer Therapies Development and is the Director of the UCLA Gastrointestinal Oncology Program. As an internationally known clinical
and translational researcher in the field of gastrointestinal cancers, Dr. Hecht has led and is currently directing small trials with new molecules as well as large international randomized Phase III trials.
Current ongoing research includes preclinical models of therapy with biological agents, early studies with gene therapy vectors and tyrosine kinase inhibitors, and leading phase II and phase III trials with novel agents. He has published widely on the molecular biology, early detection, and treatment of
gastrointestinal malignancies.
Dr. Hecht attended medical school at Eastern Virginia Medical School. He completed his internal medicine residency at Northwestern and fellowships in gastroenterology research at the University of Chicago, and in gastroenterology and medical oncology at UCLA.

Dr. Faiman has become an exemplary leader in bringing critical knowledge in cancer nursing to clinical providers- locally, nationally and internationally. She demonstrates enthusiasm for continuous learning by conducting innovative research, and has demonstrated the importance of using and integrating new medical knowledge within nursing practices. As an advanced practice nurse at the Cleveland Clinic, she led institutional quality initiatives to lessen chemotherapy wait times for cancer patients. Dr. Faiman received her Bachelor of Science degree from Ursuline Academy in 1996, a Master of Science in nursing at Kent State University in Ohio in 2002, and a PhD in clinical research and nursing from Case Western Reserve University in 2014. A founding member of the International Myeloma Foundation Nurse Leadership Board since 2006, she also successfully lobbied to enhance nurse-prescribing privileges that year. In 2014, she co-developed nurse-led consult clinics to expedite diagnosis and management of thrombosis in cancer patients, and plasma cell disorders. Faiman is a clinical member of the Case Comprehensive Cancer Center (Case CCC) under the Cancer Prevention, Control and Population (CPC) Research Program.

Faiman is currently an adult nurse practitioner in the Department of Hematology/Oncology at the Cleveland Clinic in Ohio. She has edited several books and authored many chapters and research papers, and led the development of International Myeloma management guidelines, including Editor of the 3rd Edition of the Multiple Myeloma Textbook for Nurses by ONS publishing company (2021), and the first Blood and Marrow Certification Manual for Nurses (2017). Faiman influenced cancer care practice by presenting at numerous international and US national conferences, and served as lecture chair at many of them. In 2013, Dr. Faiman served as co-chair of the 1st Nursing Symposium at the International Myeloma Workshop in Kyoto, Japan and subsequent conferences, which includes the 6th nursing symposium in Los Angeles in 2022. Her scholarly publications and presentations are highly cited by peers and colleagues. She has been invited Chair and participant in over 110 live and virtual programs over the last 5 years.

Faiman is the recipient of numerous awards and accolades. In 2023, Faiman was given the NP/PA Educator of Distinction Award in Multiple Myeloma. In 2022, Faiman was named the Top NP in Hematology/Oncology awarded by POCN; and inducted as an inaugural Fellow of Advanced Practice in Oncology (FAPO) awarded by the Advanced Practitioner Society for Hematology and Oncology (APSHO). Faiman is a Distinguished Fellow in the American Academy of Nursing (FAAN) and held an appointment on the American Board of Internal Medicine Hematology maintenance of certification committee. She received awards from 2013 Oncology Nursing Society awards for Medical excellence and Patient Education; as well as the Case Western Reserve University Dean's Legacy Award for Outstanding Doctor of Philosophy studies. Dr. Faiman was previously Editor-in-Chief of The Oncology Nurse NP/PA and section editor for American Society of Hematology Clinical News. She currently serves as Editor-in-Chief of Journal of the Advanced Practitioner in Oncology (JADPRO), the official publication of APSHO. Dr. Faiman demonstrates energy for advancing cancer care and immerses herself in national and international programs, services and leadership work within myeloma communities.

For more visit : https://my.clevelandclinic.org/staff/5953-beth-faiman